logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On June 15th, ZHOU LIU FU (06168) spent 5.17 million Hong Kong dollars to buy back 295,600 shares.

date
18:08 15/06/2026
avatar
GMT Eight
Chow Tai Fook (06168) announced on Saturday that on June 15, 2026, the company spent HK$5.157 million to repurchase 295,600 shares at a repurchase price of HK$17.23-17.47 per share.
Zhou Liufu (06168) announced on June 15, 2026, that the company will spend 5.157 million Hong Kong dollars to repurchase 29.56 thousand shares, with a repurchase price of 17.23-17.47 Hong Kong dollars per share.
Related Articles
China Stock
Huaqing Pharmaceutical (688302.SH): The final analysis results of the clinical Phase IIa trial of the drug HP515 for treating metabolic associated fatty liver disease (MAFLD) have been achieved.
HK Stock
CICC (03908) plans to issue corporate bonds not exceeding 4 billion yuan.
HK Stock
YUNJI (02670) spent 2.6375 million Hong Kong dollars to repurchase 9350 shares on June 15th.
Huaqing Pharmaceutical (688302.SH): The final analysis results of the clinical Phase IIa trial of the drug HP515 for treating metabolic associated fatty liver disease (MAFLD) have been achieved.
China Stock
CICC (03908) plans to issue corporate bonds not exceeding 4 billion yuan.
HK Stock
YUNJI (02670) spent 2.6375 million Hong Kong dollars to repurchase 9350 shares on June 15th.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.